-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*Read only for medical professionals for reference Psoriatic Arthritis Psoriatic Arthritis Psoriatic Arthritis (PsA) is an inflammatory joint disease associated with psoriasis that has a psoriatic rash and causes joint and surrounding soft tissue pain, Swelling, tenderness, stiffness and movement disorders, some patients may have sacroiliitis and (or) spondylitis, the course of the disease is protracted, easy to recur, and can develop into joint stiffness in the late stage, resulting in disability
.
Today, let Professor Zhang Zhuoli from the Department of Rheumatology and Immunology, Peking University First Hospital take us into the diversity of clinical manifestations of PsA~PsA Early diagnosis of PsA and screening of PsA treatment progress The mechanism and biomarkers of PsA Please contact authorization for reprinting - End - The medical community strives for the accuracy and reliability of its published content when it is approved, but does not make any commitment to the timeliness of the published content, and the accuracy and completeness of the cited materials (if any).
Warranty and disclaims any liability arising out of the outdated content, possible inaccuracies or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
.
.
Today, let Professor Zhang Zhuoli from the Department of Rheumatology and Immunology, Peking University First Hospital take us into the diversity of clinical manifestations of PsA~PsA Early diagnosis of PsA and screening of PsA treatment progress The mechanism and biomarkers of PsA Please contact authorization for reprinting - End - The medical community strives for the accuracy and reliability of its published content when it is approved, but does not make any commitment to the timeliness of the published content, and the accuracy and completeness of the cited materials (if any).
Warranty and disclaims any liability arising out of the outdated content, possible inaccuracies or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
.